To: Y2k_fan who wrote (142 ) 3/15/1998 12:06:00 AM From: Jeffrey L. Henken Read Replies (1) | Respond to of 2887
A comparison of AVEI and ABMI: These two companies do have more than a few things in common. Unfortunately one is a developmental stage company and the other is highly profitable. One is selling near all time highs the other? The other is ABMI a small company with a bright future! It seems that AVEI has concentrated it's efforts on the rapidly growing coronary care market. ABMI will eventually make it's presence known in this market but it takes longer for FDA approval for these indications. Actually I believe ABMI has a broader product pipeline but lets start with AVEI.biz.yahoo.com AVEI designs, develops, manufactures and markets a variety of highly specialized stent systems and percutaneous transluminal coronary angioplasty balloon catheters. For the six months ended 12/31/97, net sales rose 75% to $64.6 million. Net income rose 9% to $13.5 million. Revenues reflect increased sales of the company's stent systems following their release in certain countries internationally in 6/97. Earnings were partially offset by the addition of R&D personnel. biz.yahoo.com ABMI is a development stage company engaged in the development, manufacture and marketing of medical devices. ABMI's primary technology is directed at interventional cardiology, endovascular surgery and minimally invasive surgical devices. For the nine months ended 9/97, net sales fell 14% to $361 thousand. Net loss applicable to Common fell 25% to $1.8 million. Results reflect the ineffectiveness of the sales team, offset by productivity improvements and lower borrowings. Now that sounds pretty bad doesn't it? But I wonder how AVEI investors who bought at $10 a share feel today? ABMI is perhaps that kind of opportunity. I have talked about the catheter line up recently. So let me remind you again about the stent designs awaitind FDA approval.Message 3589688 ABMI has patented some pretty unique designs for stent technology Y2K-fan. Let me take a little of your time and tell you just what is so different and desirable to both a surgeon and his patient. What is different about the OmniStent? First off ABMI has patented a unique endless loop design which can be used with different metals other than stainless steel. Metals like Nitinol, a nickel titanium alloy. Therefore it is possible to produce a more flexible but extremely strong design which will reduce the likelihood of any necessary retreatment of the affected area while making it easier to use. The second patented design and this is really big is a bifurcated stent. This stent has a unique Y shaped stent that can be used in anything from the large blood vessels of the aortic bifurcation to any smaller bifurcated blood vessel. Believe me there are plenty of these bifurcated blood vessels. The use of this Y stent instead of two separate individual stents reduces the need for additional surgical access. This is great for both the doctor and the patient! It cuts down on the surgical time and and eliminates a second and potentially dangerous surgical prep on the opposite side of the groin. Faster for the physician, less distressful for the patient! These stents are not yet on the market. They have to go through further FDA testing before they are approved but you can certainly see why the technology that is patented here is so exciting. Is this the type of technology that makes the big guys like J&J and Guidant nervous? I bet it does! Go ABMI! Regards, Jeff